Psicosis

Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer’s disease psychosis: a phase 2,...

The Lancet Neurology Fecha de publicación: Marzo 2018 DOI: https://doi.org/10.1016/S1474-4422(18)30039-5 Autores: Clive Ballard, Carol Banister, Zunera Khan, Jeffrey Cummings, George Demos,...

Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention

The American Journal of Psychiatry Fecha de publicación: February 01, 2018, DOI: https://doi.org/10.1176/appi.ajp.2017.16080919 Autores: Delbert G. Robinson, M.D., Nina R. Schooler, Ph.D., Christoph...

Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies

The British Journal of Psychiatry Fecha de publicación: December 2017 DOI: 10.1192/bjp.bp.117.201475 Autores: John Lally, Olesya Ajnakina, Brendon Stubbs, Michael Cullinane,...

Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis

The British Journal of Psychiatry Fecha de publicación: December 2017 DOI: 10.1192/bjp.bp.117.200907 Autores: Toby Pillinger, Katherine Beck, Brendon Stubbs, Oliver D. Howes Background: The extent of metabolic and lipid...

AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial

The Lancet Psychiatry Fecha de publicación: 23 November 2017 DOI: http://dx.doi.org/10.1016/S2215-0366(17)30427-3 Autores: Prof Tom KJ Craig, Mar Rus-Calafell, PhD, Thomas Ward, DClinPsy, Prof...